SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-024167
Filing Date
2021-06-16
Accepted
2021-06-16 17:09:32
Documents
2
Period of Report
2021-06-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1606
2 EX-24 DOCUMENT attachment1.htm EX-24 4658
  Complete submission text file 0000899243-21-024167.txt   7879
Mailing Address 40 GUEST STREET SUITE 4410 BOSTON MA 02135
Business Address 40 GUEST STREET SUITE 4410 BOSTON MA 02135 617-409-5300
YUMANITY THERAPEUTICS, INC. (Issuer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MINERVA NEUROSCIENCES, INC. 1601 TRAPELO ROAD, SUITE 286 WALTHAM MA 02451
Business Address
Smith Devin Whittemore (Reporting) CIK: 0001747818 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37695 | Film No.: 211022270